Both MR phase imaging and quantitative susceptibility mapping (QSM) are used to assess the presence of chronic active multiple sclerosis lesions. It is important to evaluate which measure can detect ongoing inflammation in chronic active lesions most accurately. This study combined PK11195-PET with QSM versus phase imaging, and demonstrated that QSM can detected higher uptake of PK11195, as compared to phase imaging.
This abstract and the presentation materials are available to members only; a login is required.